NCT05145478View on ClinicalTrials.gov

CRUSH PAD: Real-world Outcomes Following Use of Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2027

Conditions
Femoral Arterial CalcificationPeripheral Arterial DiseaseClaudicationCritical Limb Ischemia
Interventions
DEVICE

Shockwave Intravascular Lithotripsy (IVL)

Eligible patients with atherosclerotic lesions in the femoral artery who either have claudication or critical limb ischemia will receive endovascular treatment in addition to be treated with Shockwave Intravascular Lithotripsy (IVL) technology.

Trial Locations (1)

06510

RECRUITING

Yale New Haven Health, New Haven

Sponsors

Collaborators (1)

Brown University
All Listed Sponsors
collaborator

Shockwave Medical, Inc.

INDUSTRY

collaborator

Brown University

OTHER

lead

Yale University

OTHER

NCT05145478 - CRUSH PAD: Real-world Outcomes Following Use of Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions | Biotech Hunter | Biotech Hunter